Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

736
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
736
Primary Lymphoid Organs01:16

Primary Lymphoid Organs

10.7K
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
10.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Secondary Lymphoid Organs01:15

Secondary Lymphoid Organs

6.3K
Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
6.3K
Lymphoid Cells and Tissues01:18

Lymphoid Cells and Tissues

1.9K
Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Validation of the newly introduced Deauville Score 5a in patients treated for advanced-stage classic Hodgkin Lymphoma.

Blood advances·2026
Same author

A targeted circulating tumor DNA landscape of copy number aberrations in large B-cell lymphomas.

Leukemia·2026
Same author

Long-Term Quality of Life in 1777 Persons With Hodgkin Lymphoma and 6166 Matched Comparators.

American journal of hematology·2026
Same author

Atmospheric mercury monitoring data across Italy: A multi-year national dataset (2020 - 2023).

Data in brief·2026
Same author

AVD is an effective chemotherapy backbone in first-line treatment of older patients with classical Hodgkin lymphoma.

Blood advances·2026
Same author

Paraneoplastic Neuro-Ophthalmologic Symptoms as Initial Manifestation of Hodgkin Lymphoma.

Hematology reports·2026

Related Experiment Video

Updated: Oct 15, 2025

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
12:16

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

15.0K

[Lymphoid malignancy treatment].

Judit Jørgensen, Peter Kamper, Francesco d'Amore1

  • 1frandamo@rm.dk.

Ugeskrift for Laeger
|October 28, 2021
PubMed
Summary

Technological advances deepen understanding of lymphoid malignancies, driving development of novel therapies. Precision medicine combining diagnostics, therapeutics, and surveillance offers improved outcomes for patients with high unmet needs.

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Recent technological advancements have significantly improved the understanding of lymphoid malignancy pathogenesis.
  • This enhanced knowledge fuels the development of innovative therapeutic strategies.

Purpose of the Study:

  • To review the impact of new knowledge on lymphoid malignancy treatment.
  • To highlight the potential of precision medicine in improving patient outcomes.

Main Methods:

  • Review of recent technological advances in understanding lymphoid malignancies.
  • Analysis of novel therapeutic agents and immune strategies.
  • Evaluation of precision medicine approaches in diagnostics, therapy, and surveillance.

Main Results:

More Related Videos

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.3K
Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

15.4K

Related Experiment Videos

Last Updated: Oct 15, 2025

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
12:16

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

15.0K
Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.3K
Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

15.4K
  • Increased understanding of pathogenetic mechanisms in lymphoid malignancies.
  • Development of novel therapeutic agents and immune-based strategies.
  • Potential for significant improvements in life expectancy and quality of life.

Conclusions:

  • Precision medicine, integrating diagnostics, therapeutics, and surveillance, is key to advancing care.
  • These approaches offer hope for substantial improvements, especially for patients with high unmet clinical needs.